Bringing regenerative medicines to the clinic: the future for regulation and reimbursement.

Bringing regenerative medicines to the clinic: the future for regulation and reimbursement.

Item
http://www.wikidata.org/entity/Q38632641
Opportunities and challenges for the cellular immunotherapy sector: a global landscape of clinical trials.Opening the gateways to market and adoption of regenerative medicine? The UK case in context.A quantitative, multi-national and multi-stakeholder assessment of barriers to the adoption of cell therapies.Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation.Addressing Pressing Needs in the Development of Advanced Therapies.Gene therapy: evidence, value and affordability in the US health care system.Gene therapies: the challenge of super-high-cost treatments and how to pay for them.Liver tissue engineering: From implantable tissue to whole organ engineering.Insurance systems and reimbursement concerning research and development of regenerative medicine in Japan.
P2860

Bringing regenerative medicines to the clinic: the future for regulation and reimbursement.

Item
http://www.wikidata.org/entity/Q38632641
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Bringing regenerative medicine ...... regulation and reimbursement.
@en
type
label
Bringing regenerative medicine ...... regulation and reimbursement.
@en
prefLabel
Bringing regenerative medicine ...... regulation and reimbursement.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Bringing regenerative medicine ...... r regulation and reimbursement
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698